Renaissance Capital logo

FutureTech II Acquisition Priced, Nasdaq: FTII

Blank check company targeting the disruptive technology sector in the US (pending: Longevity Biomedical).

Industry: SPAC

Latest Trade: $11.10 0.00 (0.0%)

First Day Return: +0.1%

Return from IPO: +11.0%

Industry: SPAC

We are a newly organized, blank check company. Our efforts to identify a prospective target business will not be limited to a particular industry or geographic location, although we currently intend to focus on opportunities to acquire U.S. companies in the disruptive technology sector, for example, artificial intelligence, or AI, robotic process automation, or Robotics, and any other related technology innovations market. We shall not undertake our initial business combination with any entity with its principal business operations in China (including Hong Kong and Macau). While we may pursue an acquisition opportunity in any business industry or sector, we intend to capitalize on our management team’s differentiated ability to source, acquire and manage a business in the technology industry. Our management team has an extensive track record of creating value for stockholders by acquiring strong businesses at disciplined valuations, investing in growth while fostering financial discipline and ultimately improving financial results. Our management team is led by Yuquan Wang, our Chief Executive Officer and Chairman of the Board, Michael Greenall, our Chief Financial Officer, and Neil Bush, Aroop Zutshi and Jeffrey Mosley, our independent director nominees.
more less
IPO Data
IPO File Date 12/23/2021
Offer Price $10.00
Price Range $10.00 - $10.00
Offer Shares (mm) 10.0
Deal Size ($mm) $100
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 02/15/2022
Offer Price $10.00
Price Range $10.00 - $10.00
Offer Shares (mm) 10.0
Deal Size ($mm) $100
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
D. Boral Capital
Company Data
Headquarters New Rochelle, NY, United States
Founded 2021
Employees at IPO 2

FutureTech II Acquisition (FTII) Performance